TIL

Instil Bio, Inc.

TIL · CIK 1789769 · Annual (10-K) · Last 4 years

Financial Trends

Revenue
20212024
Net Income−$74M
20212024
Operating CF−$56M
20212024
Free Cash Flow−$56M
20212024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue———$0.0B
Cost of Revenue————
Gross Profit————
R&D Expense—$0.0B$0.1B$0.1B
SG&A Expense————
Operating Income$-0.1B$-0.2B$-0.2B$-0.2B
Net Income$-0.1B$-0.2B$-0.2B$-0.2B
EPS (Basic)$-11.39$-24.00$-1.72$-1.48
EPS (Diluted)$-11.39$-24.00$-1.72$-1.48

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.3B$0.3B$0.5B$0.6B
Current Assets$0.1B$0.2B$0.3B$0.5B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.1B$0.1B$0.1B$0.1B
Current Liabilities$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.2B$0.2B$0.4B$0.6B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.1B$-0.1B$-0.2B$-0.1B
Investing Cash Flow$0.1B$0.0B$0.1B$-0.5B
Capital Expenditures$0.0B$0.0B$0.1B$0.1B
Financing Cash Flow$0.0B$0.0B$0.1B$0.4B
← Companies